Treatment outcomes of Impella 5.0/5.5 in patients with cardiogenic shock

Treatment outcomes of Impella 5.0/5.5 in patients with cardiogenic shock - BRAVE-HEART

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037457

Enrollment

500

Registered

2025-07-17

Start date

2025-07-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R57.0

Interventions

Group 1: Patients who were treated for cardiogenic shock with a surgically implanted microaxial flow pump (Impella 5.0/5.5)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Mechanical circulatory support with Impella 5.0 Mechanical circulatory support with Impella 5.5

Exclusion criteria

Exclusion criteria: Mechanical circulatory support with Impella CP Mechanical circulatory support with Impella 2.5 Mechanical circulatory support with Impella RP

Design outcomes

Primary

Measure	Time frame
In-hospital mortality	—

Secondary

Measure	Time frame
One-year mortality Cerebral Performance Category (CPC) score at discharge	—

Countries

Austria, Belgium, Germany, Italy, Spain, United Kingdom

Contacts

Public ContactEnzo Lüsebrink

Herzzentrum des Universitätsklinikums Bonn

enzo.luesebrink@ukbonn.de+49 22828715217

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026